Internal Medicine · Cambridge, MA
NPI
1922395664
Since 2011
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
330 Mount Auburn St
Cambridge, MA, 02138
Phone (617) 492-3500
Groups this clinician bills Medicare through
Medicare paid, 2024
$93K
1,268 services
Medicare patients, 2024
460
Average age 73
Drug cost, 2024
$5.6M
2,557 prescriptions
Company payments, 2025
$374
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jianfeng Wang was code 99214 (office e&m - established), 618 times for 374 patients. In total Jianfeng Wang billed 1,268 services in 14 codes, and Medicare paid $93K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-07-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 618 | 374 | $65.48 | $40K |
| 99232 Hospital E&M - Subsequent | Facility | 164 | 46 | $57.86 | $9,489 |
| 99215 Office E&M - Established | Facility | 133 | 83 | $105.28 | $14K |
| 99233 Hospital E&M - Subsequent | Facility | 96 | 29 | $88.63 | $8,508 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 58 | 29 | $22.87 | $1,326 |
| 99204 Office E&M - New | Facility | 55 | 55 | $88.26 | $4,854 |
| 99223 Hospital E&M - Initial | Facility | 43 | 34 | $127.59 | $5,486 |
| 99205 Office E&M - New | Facility | 39 | 39 | $125.37 | $4,889 |
| 99213 Office E&M - Established | Facility | 36 | 35 | $36.71 | $1,322 |
| 99222 Hospital E&M - Initial | Facility | 20 | 18 | $99.04 | $1,981 |
By year: 2022 $104K for 1,291 services; 2023 $97K for 1,205 services; 2024 $93K for 1,268 services.
Medicare prescription drug claims, 2024
In 2024, the drug Jianfeng Wang prescribed most often to Medicare patients was Eliquis (Apixaban), with 165 prescriptions and refills. In total Jianfeng Wang wrote 2,557 Medicare prescriptions that cost $5.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 165 | 208 | 44 | $121K |
| Oxycodone Hcl Generic | 155 | 155 | 30 | $3,048 |
| Letrozole Generic | 108 | 172 | 26 | $1,602 |
| Morphine Sulfate Er Morphine Sulfate | 100 | 100 | 24 | $3,880 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 99 | 99 | 31 | $2,329 |
| Tamoxifen Citrate Generic | 97 | 174 | 24 | $2,009 |
| Pantoprazole Sodium Generic | 81 | 117 | 27 | $577 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 77 | 77 | 27 | $3,763 |
| Venclexta Venetoclax | 74 | 74 | Under 11 | $651K |
| Anastrozole Generic | 63 | 85 | 15 | $715 |
| Ondansetron Hcl Generic | 60 | 60 | 34 | $581 |
| Zolpidem Tartrate Generic | 54 | 54 | 14 | $430 |
| Revlimid Lenalidomide | 48 | 48 | Under 11 | $672K |
| Alprazolam Generic | 46 | 48 | 16 | $108 |
| Lenalidomide Generic | 44 | 44 | Under 11 | $502K |
Brand drugs: - claims; generic drugs: 1,954 claims; opioid claims: 492.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jianfeng Wang $374 ($374 in general payments such as food, travel and fees) from 12 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $68.49.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 1 | $68.49 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $51.1 |
| Gilead Sciences, Inc. GILD | 2 | $44.45 |
| Astellas Pharma US Inc 4503.T | 2 | $37.21 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $25.81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $24.53 |
| Incyte Corporation INCY | 1 | $23.23 |
| Janssen Biotech, Inc. JNJ | 1 | $21.49 |
| Stemline Therapeutics Inc. | 1 | $21.28 |
| EMD Serono, Inc. MRK.DE | 1 | $21.04 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.